1.
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield
by Montes de Jesus, F. M
European journal of nuclear medicine and molecular imaging, 2019-08-24, Vol.47 (3), p.529-536
2.
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
by Law, Ian
European journal of nuclear medicine and molecular imaging, 2019-03, Vol.46 (3), p.540-557
3.
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma...
by Taieb, D
European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (10), p.2112-2137
4.
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
by Thijssen, Elisabeth H
Nature medicine, 2020-03-01, Vol.26 (3), p.387-397
5.
Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis
by Bucerius, Jan
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (4), p.780-792
6.
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysi...
by Bonomo, Pierluigi
European journal of nuclear medicine and molecular imaging, 2018-06-09, Vol.45 (12), p.2122-2138
7.
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
by Kroth, Heiko
European journal of nuclear medicine and molecular imaging, 2019-07-01, Vol.46 (10), p.2178-2189
8.
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy
by Nielsen, Berit Dalsgaard
European journal of nuclear medicine and molecular imaging, 2018-04-18, Vol.45 (7), p.1119-1128
9.
EANM/EARL harmonization strategies in PET quantification: From daily practice to multicentre oncological studies
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (S1), p.17-31
10.
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma : a systematic review and meta-analysis
by Burggraaff, Coreline N
European journal of nuclear medicine and molecular imaging, 2019-01, Vol.46 (1), p.65-79
11.
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations
by Mayerhoefer, Marius E
European journal of nuclear medicine and molecular imaging, 2019-08-13, Vol.47 (1), p.51-60
12.
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
by Sepulcre, Jorge
Nature medicine, 2018-12, Vol.24 (12), p.1910-1918
13.
Feasibility of state of the art PET/CT systems performance harmonisation
by Kaalep, Anes
European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (8), p.1344-1361
14.
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)
by Nanni, Cristina
European journal of nuclear medicine and molecular imaging, 2017-12-21, Vol.45 (5), p.712-719
15.
Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma
by Zaidi, Habib
European journal of nuclear medicine and molecular imaging, 2012-05, Vol.39 (5), p.881-891
16.
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by t...
by Slart, Riemer H. J. A
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (7), p.1250-1269
17.
Brown adipose tissue is associated with cardiometabolic health
by Becher, Tobias
Nature medicine, 2021-01, Vol.27 (1), p.58-65
18.
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
by Camus, V
European journal of nuclear medicine and molecular imaging, 2012-01-18, Vol.39 (4), p.621-631
19.
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
by Cai, Weibo
European journal of nuclear medicine and molecular imaging, 2007-06, Vol.34 (6), p.850-858
20.
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
by Giovanella, Luca
European journal of nuclear medicine and molecular imaging, 2019-09-04, Vol.47 (1), p.61-77
